Preparation of suspensions

US10167203B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10167203-B2
Application numberUS-201514960926-A
CountryUS
Kind codeB2
Filing dateDec 7, 2015
Priority dateDec 24, 2004
Publication dateJan 1, 2019
Grant dateJan 1, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method for preparing a suspension of LDH particles comprising the steps of: preparing LDH precipitates by coprecipitation to form a mixture of LDH precipitates and solution; separating the LDH precipitates from the solution; washing the LDH precipitates to remove residual ions; mixing the LDH precipitates with water; and subjecting the mixture of LDH particles and water to a hydrothermal treatment step by heating to a temperature of from greater than 80° C. to 150° C. for a period of about 1 hour to about 144 hours to form a well dispersed suspension of LDH particles in water, wherein said LDH particles in suspension comprise platelets having a maximum particle dimension of up to 400 nm.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for preparing a suspension of LDH particles comprising the steps of: a) preparing LDH precipitates by coprecipitation to form a mixture of LDH precipitates and solution, wherein the LDH precipitates and the solution formed in step (a) are left in contact with each other for a period not exceeding 30 minutes; b) separating the LDH precipitates from the solution; c) washing the LDH precipitates to remove residual ions; d) mixing the LDH precipitates with water; and e) subjecting the mixture of LDH particles and water from step (d) to a hydrothermal treatment step by heating to a temperature of from greater than 80° C. to 150° C. for a period of about 1 hour to about 144 hours to form a dispersed suspension of non-aggregated LDH particles in water, wherein said LDH particles in suspension comprise platelets having a maximum particle dimension of up to 400 nm. 2. A method as claimed in claim 1 wherein step (e) comprises subjecting the mixture of LDH particles and water from step (d) to a hydrothermal treatment step by heating to a temperature of from greater than 80° C. to 150° C. for a period of about 1 hour to about 2 hours. 3. A method as claimed in claim 1 wherein the platelets exhibit a particle size distribution of no more than about ±27%, based upon the peak value and the peak width at half maximum from the particle size distribution of an intensity average using photon correlation spectroscopy (PCS) measurement. 4. A method as claimed in claim 1 wherein the LDH precipitates and the solution formed in step (a) are left in contact with each other for a period not exceeding 20 minutes. 5. A method as claimed in claim 1 wherein the LDH precipitates and the solution formed in step (a) are left in contact with each other for a period not exceeding 10 minutes. 6. A method as claimed in claim 1 wherein the LDH precipitates and the solution formed in step (a) are left in contact with each other for a period not exceeding 5 minutes. 7. A method as claimed in claim 1 wherein the LDH precipitates and the solution formed in step (a) are left in contact with each other for a period not exceeding 1 minute. 8. A method as claimed in claim 1 wherein the LDH precipitates and solution formed in step (a) are stirred. 9. A method as claimed in claim 1 wherein the hydrothermal treating step is carried out while suppressing boiling. 10. A method as claimed in claim 1 wherein in step (a) a mixed metal ion solution and an alkaline solution are rapidly mixed together. 11. A method as claimed in claim 10 wherein the mixed metal ion solution and the alkaline solution are added together within a time period of less than 1 minute. 12. A method as claimed in claim 1 wherein precipitation in step (a) takes place at a temperature ranging from room temperature up to about 50° C. 13. A method as claimed in claim 1 wherein the LDH precipitates are washed one or more times with deionized water following separation from the solution. 14. A method as claimed in claim 1 wherein the mixture of water and LDH precipitates is held at the elevated temperature for a period of from 2-48 hours in step (e). 15. A method as claimed in claim 13 wherein the mixture of water and LDH precipitates is held at the elevated temperature for a period of from 1-24 hours. 16. A method as claimed in claim 1 wherein the largest dimension of the platelets in the suspension predominantly falls within the range of 20-400 nm. 17. A method as claimed in claim 1 wherein the largest dimension of the platelets in the suspension predominantly falls within the range of 40-300 nm. 18. A method as claimed in claim 1 wherein the suspension contains up to 10% w/w LDH platelets. 19. A method as claimed in claim 1 wherein the suspension contains up to 5% w/w LDH platelets. 20. A method as claimed in claim 1 wherein the suspension contains up to about 1% w/w LDH platelets. 21. A method as claimed in claim 1 wherein the suspension contains less than 1% w/w LDH particles. 22. A method as claimed in claim 1 further comprising the step of removing at least some of the water from the suspension to concentrate the particles to form a more concentrated suspension. 23. A method as claimed in claim 1 wherein step (d) comprises mixing the LDH precipitates with water in order to disperse the LDH precipitates in the water and to break up any loose aggregates of LDH precipitates into platelets. 24. A method for forming LDH particles comprising forming a suspension as claimed in claim 1 and separating the LDH particles from the suspension.

Assignees

Inventors

Classifications

  • C01F7/784Primary

    Layered double hydroxide, e.g. comprising nitrate, sulfate or carbonate ions as intercalating anions · CPC title

  • B82Y30/00Primary

    Nanotechnology for materials or surface science, e.g. nanocomposites · CPC title

  • Compounds containing iron, with or without oxygen or hydrogen, and containing two or more other elements · CPC title

  • Particles with a specific particle size distribution · CPC title

  • bimodal size distribution · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10167203B2 cover?
A method for preparing a suspension of LDH particles comprising the steps of: preparing LDH precipitates by coprecipitation to form a mixture of LDH precipitates and solution; separating the LDH precipitates from the solution; washing the LDH precipitates to remove residual ions; mixing the LDH precipitates with water; and subjecting the mixture of LDH particles and water to a hydrothermal trea…
Who is the assignee on this patent?
Univ Queensland
What technology area does this patent fall under?
Primary CPC classification C01F7/784. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).